Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Somatostatinoma 1Small Cell Lung Carcinoma 1Glioblastoma 1Gallbladder Neoplasms 1Cholangiocarcinoma 1

Interventions

Leucovorin 2Fluorouracil 2Everolimus 2romidepsin 1pentetreotide 1irinotecan sucrosofate 1dehydroftorafur 1Panobinostat 1Oxaliplatin 1Octreotide 1Doxorubicin 1Bortezomib 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Somatostatinoma × irinotecan sucrosofate × Clear all
NCT03736720 2025-01-30

Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin

Roswell Park Cancer Institute

Phase 2 Terminated
11 enrolled 17 charts

Somatostatinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡